Infectious Disease Alert – November 1, 2021
November 1, 2021
View Issues
-
COVID-19 Vaccination and Myocarditis
Receipt of a COVID-19 mRNA vaccine is associated with a small but real risk of development of myocarditis, predominantly in young males. The vast majority of cases are mild, self-limited, and require no intervention.
-
Prophylactic Probiotics Do Not Reduce the Risk for Developing Ventilator-Associated Pneumonia
A multicenter, randomized, placebo-controlled clinical trial revealed the use of prophylactic probiotics did not reduce the risk for developing ventilator-associated pneumonia or improve other outcomes for intensive care unit patients, compared to placebo.
-
IDWeek 2021: Baricitinib for COVID-19 Patients Receiving Invasive Mechanical Ventilation or ECMO
Baricitinib significantly reduced mortality in patients with COVID-19 receiving mechanical ventilation or extracorporeal membrane oxygenation.
-
IDWeek 2021: Gram-Negative Bacteremia: Are Follow-Up Blood Cultures Routinely Necessary?
A study of significantly immunocompromised patients with gram-negative bacteremia concluded that the routine use of follow-up blood cultures to document clearance is not warranted.
-
IDWeek 2021: Skipping Along with Staphylococcus aureus
A single set of blood cultures may be inadequate to document clearance of Staphylococcus aureus bacteremia in some patients.
-
Can Antibiotics Lead to Colon Cancer?
Swedish researchers saw an association between frequent antibiotic use and proximal colorectal cancer.
-
Bacillus cereus Causing an Anthrax-Like Pneumonia
Bacillus cereus group organisms may cause a rapidly fatal pulmonary infection consistent with anthrax.
-
Malaria: At Last a Vaccine
The World Health Organization has recommended the use of the first effective malaria vaccine.
-
Infectious Disease Alert Updates
A Reservoir of Pharyngeal GC; Difficult-to-Treat vs. Standard Multidrug Resistance